TipRanks
TipRanksTop Financial ExpertsInsidersShawn Tomasello

Shawn Tomasello Insider Profile

11 Followers
Shawn Tomasello, Director at 4D Molecular Therapeutics, holds ― shares in 4D Molecular Therapeutics (Ticker: FDMT), holds 22.73K shares in Cabaletta Bio (Ticker: CABA), holds 70.00K shares in Kalaris Therapeutics (Ticker: KLRS). Most recently, Shawn Tomasello ― shares of 4D Molecular Therapeutics on ― for an estimated value of ―.
See the Hottest Stocks Based on Insider Trading >
tipranks
Shawn Tomasello

Shawn Tomasello
4D Molecular Therapeutics (FDMT)
Director

Ranked #55,214 out of 109,349 Corporate Insiders

Profitable Transactions

33%
1 out of 3 Profitable Transactions

Average Return

-0.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$333K
46.98%
42.71%
10.31%
0.00%
0.00% Others
A breakdown of Shawn Tomasello's holdings
See the Top Stocks by Insiders

Insider Roles

Abeona Therapeutics
(ABEO)
Director
Kalaris Therapeutics
(KLRS)
Director
Cabaletta Bio
(CABA)
Director
4D Molecular Therapeutics
(FDMT)
Director
+1 other positions
Roles that Shawn Tomasello holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Diplomat Pharmacy
(DPLO)
Rating:Informative Sell
Date:Jun 05, 2018 - Jun 05, 2019
Return:+81.10%
The most profitable trade made by Shawn Tomasello
See the Latest Stocks Traded by Insiders

Shawn Tomasello's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
FDMT
4D Molecular Therapeutics
―
Director
―
―
KLRS
Kalaris Therapeutics
Jun 07, 2024
Director
Uninformative Buy
―
$142.10K
GMDAQ
Gamida Cell
Feb 02, 2024
―
Uninformative Buy
―
$3.87K
CABA
Cabaletta Bio
Jan 21, 2026
Director
Informative Buy
50.22K
$34.31K
KITE
Kite Pharma Inc
Oct 05, 2017
―
Uninformative Sell
2.90M
$11.51M
URGN
Urogen Pharma
―
Director
―
―
PRNB
Principia Biopharma
―
―
―
―
ABEO
Abeona Therapeutics
May 22, 2020
Director
Uninformative Buy
―
$156.33K
TCRR
TCR2 Therapeutics
―
―
―
―
PCYC
Pharmacyclics
May 27, 2015
―
Uninformative Sell
13.06M
―
DPLO
Diplomat Pharmacy
Feb 10, 2020
―
Uninformative Sell
133.04K
$0.00
List of latest transactions for each holding click on a transaction to see Shawn Tomasello's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Shawn Tomasello insider profile FAQ

What is the percentage of profitable transactions made by Shawn Tomasello?
The percentage of profitable transactions made by Shawn Tomasello is 33%.
    What is the average return per transaction made by Shawn Tomasello?
    The average return per transaction made by Shawn Tomasello is -0.50%.
      What stocks does Shawn Tomasello hold?
      Shawn Tomasello holds: FDMT, KLRS, GMDAQ, CABA, KITE, URGN, PRNB, ABEO, TCRR, PCYC, DPLO stocks.
        What was Shawn Tomasello’s latest transaction?
        Shawn Tomasello latest transaction was an Uninformative Buy of ―.
          What was Shawn Tomasello's most profitable transaction?
          Shawn Tomasello’s most profitable transaction was an Informative Sell of DPLO stock on June 5, 2018. The return on the trade was 81.10%.
            What is Shawn Tomasello's role in 4D Molecular Therapeutics?
            Shawn Tomasello's role in 4D Molecular Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.